Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg. 2014 Oct; 260(4):608-14; discussion 614-6.

View in: PubMed

subject areas

Axilla
Breast Neoplasms
Chemotherapy, Adjuvant
Female
Humans
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Mastectomy, Segmental
Neoadjuvant Therapy
Neoplasm Staging
Prospective Studies
Receptor, ErbB-2

authors with profiles

KELLY K HUNT
ELIZABETH ANN MITTENDORF